Trastuzumab emtanzin in the treatment of HER2-positive metastatic breast cancer in patients with visceral crisis

Autor:	L.A. Ryadinskaya Ryadinskaya, A.E. Storozhakova Storozhakova, N.A. Abramova Abramova, M.A. Teplyakov Teplyakov, I.L. Popova Popova, N.M. Tikhanovskaya Tikhanovskaya, M.O. Yezhova Yezhova, L Yu Vladimirova, K.A. Novoselova Novoselova, A.A. Lyanova Lyanova
Rok vydání:	2019
Předmět:	Oncology medicine.medical_specialty business.industry Trastuzumab Internal medicine medicine In patient medicine.disease business Metastatic breast cancer medicine.drug
Zdroj:	Pharmateca. :58-63
ISSN:	2414-9128
DOI:	10.18565/pharmateca.2019.7.58-63
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f469d7dd9ac616bdd15d3f5e3aa73aee https://doi.org/10.18565/pharmateca.2019.7.58-63 Zobrazit plný text záznamu